A diabetes drug has gotten endorsement from the Food and Medication Organization (FDA) to likewise be utilized as a weight reduction medicine in patients with corpulence.
The prescription, Wegovy, is a higher portion of the diabetes drug semaglutide delivered by Novo Nordisk.
It's the primary medication for ongoing weight the executives that has been supported by the FDA since 2014.
